Leading academic researchers are ready to share their stories of success using the DELopen platform. DNA encoded library (DEL) technology involves a novel affinity selection process that integrates chemistry, biology, bioinformatics and computational chemistry to facilitate a rapid drug discovery process, allowing access to more chemical space at lower costs.
Attend this webinar to learn how DELopen can offer free access to billions of compounds and how to launch your drug discovery timelines forward.